The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis

Journal of Neuroimmunology

Volumn 107, Issue 2, 2000, Pages 161-166

  Hohlfeld, Reinhard ^a,b   Kerschensteiner, Martin ^a,b   Stadelmann, Christine ^c   Lassmann, Hans ^c   Wekerle, Hartmut ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Autoimmunity; Immunotherapy; Multiple sclerosis; Neuroprotection; Neurotrophic factors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MYELIN BASIC PROTEIN; NEUROTROPHIC FACTOR;

AUTOIMMUNITY; CELLULAR IMMUNITY; CONFERENCE PAPER; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFLAMMATION; LEUKOENCEPHALOPATHY; MULTIPLE SCLEROSIS; NEUROPROTECTION; PRIORITY JOURNAL; T LYMPHOCYTE;

BRAIN-DERIVED NEUROTROPHIC FACTOR; HUMANS; MULTIPLE SCLEROSIS; NEUROPROTECTIVE AGENTS; T-LYMPHOCYTES;

EID: 0034710340     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00233-2     Document Type: Conference Paper

References (42)

1. Batchelor P.E., Liberatore G.T., Wong J.Y.F., Porritt M.J., Frerichs F., Donnan G.A., et al. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19:1999;1708-1716.
2. Besser M., Wank R. Clonally restricted production of the neurotrophins, brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J. Immunol. 162:1999;6303-6306.
3. Cohen I.R. The cognitive paradigm and the immunological homunculus. Immunol. Today. 13:1992;490-494.
4. Compston A. Future prospects for the management of multiple sclerosis. Ann. Neurol. 36:1994;S146-S150.
5. Ehrhard P.B., Erb P., Graumann U., Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc. Natl. Acad. Sci. USA. 90:1993;10984-10988.
6. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain. 120:1997;393-399.
7. + T lymphocytes: Green fluorescent protein engineered, encephalitogenic T cells used to illuminate immune responses in the brain. Nature Med. 5:1999;843-847.
8. Gravel C., Götz R., Lorrain A., Sendtner M. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nature Med. 3:1997;765-769.
9. Hirschberg D.L., Moalem G., He J., Mor F., Cohen I.R., Schwarz M. Accumulation of passively transferred primed T cells independently of their antigen specificity following nervous system trauma. J. Neuroimmunol. 89:1998;88-96.
10. Hofer M., Pagliusi S.R., Hohn A., Leibrock A., Barde Y.-A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9:1990;2459-2464.
11. Hohlfeld R. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain. 120:1997;865-916.
12. Kerschensteiner M., Gallmeier E., Behrens L., Klinkert W.E.F., Kolbeck R., Hoppe E., et al. Activated human T cells, B cells and monocytes produce brain-derived neurotrophic factor (BDNF) in vitro and in brain lesions: A neuroprotective role of inflammation? J. Exp. Med. 189:1999;865-870.
13. Klein R., Nanduri V., Jing S., Lamballe F., Tapley P., Bryant S., et al. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 66:1991;395-403.
14. Kobayashi N.R., Fan D.-P., Giehl K.M., Bedard A.M., Wiegand S.J., Tetzlaff W. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Tα1-tubulin mRNA expression, and promote axonal regeneration. J. Neurosci. 17:1997;9583-9595.
15. Kramer R., Zhang Y., Gehrmann J., Gold R., Thoenen H., Wekerle H. Gene transfer through the blood-nerve barrier: Nerve growth factor engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis. Nature Med. 1:1995;1162-1166.
16. Labouyrie E., Dubus P., Groppi A., Mahon F.X., Ferrer J., Parrens M., et al. Expression of neurotrophins and their receptors in human bone marrow. Am. J. Pathol. 154:1999;405-415.
17. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 341:1989;149-152.
18. Lewin G.R., Barde Y.-A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
19. Lomen-Hoerth C., Shooter E.M. Widespread neurotrophin receptor expression in the immune system and other nonneuronal rat tissues. J. Neurochem. 64:1995;1780-1789.
20. McTigue D.M., Horner P.J., Stokes B.T., Gage F.H. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci. 18:1998;5354-5365.
21. Meinl E., Hoch R.M., Dornmair K., De Waal Malefijt R., Bontrop R.E., et al. Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. Am. J. Pathol. 150:1997;445-453.
22. Mitsumoto H., Ikeda K., Klinkosz B., Cedarbaum J.M., Wong V., Lindsay R.M. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science. 265:1994;1107-1110.
23. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nature Med. 5:1999;49-55.
24. Moser H.W. Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy. Brain. 120:1997;1485-1508.
25. Naparstek Y., Ben-Nun A., Holoshitz J., Reshef T., Frenkel A., Rosenberg M., et al. T lymphocyte line producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur. J. Immunol. 13:1983;418-423.
26. Neumann H., Misgeld T., Matsumuro K., Wekerle H. Neurotrophins inhibit class II inducibility of microglia: Involvement of the p75 receptor. Proc. Natl. Acad. Sci. USA. 95:1998;5779-5784.
27. Noseworthy J.H., Gold R., Hartung H.-P. Treatment of multiple sclerosis: Recent trials and future perspectives. Curr. Opin. Neurol. 12:1999;279-293.
28. Perry V.H., Andersson P.-B., Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16:1993;268-273.
29. Ransohoff R.M., Tani M. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation? Trends Neurosci. 21:1998;154-159.
30. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G.J., Yoles E., Fraidakis M., et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nature Med. 4:1998;814-821.
31. Sagot Y., Vejsada R., Kato A.C. Clinical and molecular aspects of motor-neurone diseases: Animal models, neurotrophic factors and Bcl-2 oncoprotein. Trends Pharmacol. Sci. 18:1997;330-337.
32. Santambrogio L., Benedetti M., Chao M.V., Muzaffar R., Kulig K., Gabelli N., et al. Nerve growth factor production by lymphocytes. J. Immunol. 153:1994;4488-4495.
33. Schwartz M., Moalem G., Leibowitz-Amit R., Cohen I.R. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 22:1999;295-299.
34. Serpe C.J., Kohm A.P., Huppenbauer C.B., Sanders V.J., Jones K.J. Exacerbation of facial motor-neuron loss after facial nerve transection in severe combined immunodeficient (SCID) mice. J. Neurosci. RC7:1999;1-5.
35. Soontornniyomkij V., Wang G., Pittman C.A., Wiley C.A., Achim C.L. Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis. Neuropathol. Appl. Neurobiol. 24:1999;453-460.
36. Thoenen H., Castrén E., Berzaghi M., Blöchl A., Lindholm D. Racagni G., Brunello N., Langer S.Z. Recent Advances in the Treatment of Neurodegenerative Disorders and Cognitive Dysfunction. 1994;197-203 Karger, Basel.
37. Torcia M., Bracci-Laudiero L., Lucibello M., Nencioni L., Labardi D., Rubatelli A., et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell. 85:1996;345-356.
38. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mörk S., Bö L. Axonal transection in the lesion of multiple sclerosis. N. Engl. J. Med. 338:1998;278-285.
39. Wei R.T., Jonakait G.M. Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta 1 (TGF-beta 1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. J. Neuroimmunol. 95:1999;8-18.
40. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., Linington C. Animal models. Ann. Neurol. 36:1994;S47-S53.
41. Wekerle H., Linington C., Lassmann H., Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci. 9:1986;271-277.
42. Yan Q., Elliott J., Snider W.D. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature. 360:1992;753-755.